China's WuXi AppTec rises on strong first-half results, annual outlook

WuXi AppTec

29/07/2025 03:02

** Hong Kong-listed shares of WuXi AppTec 2359.HK jump 8.4% to HK$108.8, their highest since January 2023

** Stock on course for a sixth consecutive session of gains, if current trend holds
** Stock posts its biggest intraday pct rise since July 11 and is top pct gainer in Hang Seng Biotech Index .HSHKBIO, which is up 1.1%

** Shanghai-listed stock 603259.SS gains 2.1% to 93.53 yuan, its highest since October 2023

** The Chinese new drug R&D and manufacturing services group said its first-half net profit jumps 101.9% y/y

** Co raises full-year overall revenue forecast to 42.5-43.5 billion yuan ($5.92-$6.06 billion) from previous forecast of 41.5-43 billion yuan

** The blue-chip CSI 300 Index .CSI300 and Shanghai Composite Index .SSEC both slip 0.1%

** Hang Seng Commerce & Industry Index .HSNC slips 0.7% and benchmark Hang Seng Index .HSI eases 0.6%

** YTD, Hong Kong stock up 89.8%, Shanghai shares up 69.5%

($1 = 7.1778 Chinese yuan)

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))